Enhances Fat Metabolism: L-Carnitine aids in the transport of fats for energy production
"And remember these are associations, not causations, so it's not to say that GLP-1 use causes NAION or worsening retinopathy, but their use is associated with these conditions." "From an ophthalmologic standpoint, these findings underscore the importance of baseline and follow-up eye examinations for patients starting GLP-1 therapy, especially those with pre-existing retinal or optic nerve risk factors." The expert added that while the benefits of GLP-1 medications in reducing cardiovascular and metabolic risks are "substantial," patients should be counseled on potential visual side effects, and "any sudden visual symptoms should prompt immediate ophthalmic referral." For more Health articles, visit www.foxnews.com/health Novo Nordisk, maker of Ozempic and Wegovy, provided the following statement when contacted by Fox News Digital
Typical titration schedules begin at 100mcg per dose, escalating by 100mcg increments every 710 days to identify the minimum effective dose while monitoring for adverse events
During pregnancy, the goal isnt weight loss
The science of transdermal patches: what works and what doesn't Transdermal patches aren't a new idea
Sato H, Tamba M, Ishii T, Bannai S
